Evidence map›Paper›PMID 38605224›Full record

ArticleThe EMBO journal2024

TEAD2 initiates ground-state pluripotency by mediating chromatin looping.

Rong Guo, Xiaotao Dong, Feng Chen, Tianrong Ji, Qiannan He, Jie Zhang, Yingliang Sheng, Yanjiang Liu, Shengxiong Yang, Weifang Liang and 5 more

Open access · diamondAbstract read
In one paragraph

Article in The EMBO journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Rong Guo *State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China.
Xiaotao Dong *Center for Health Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Feng ChenState Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China.
Tianrong JiCenter for Health Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Qiannan HeState Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China.
Jie ZhangState Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China.ORCID http://orcid.org/0000-0001-8437-1471
Yingliang ShengState Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China.ORCID http://orcid.org/0009-0007-0680-2636
Yanjiang LiuState Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China.
Shengxiong YangState Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China.
Weifang LiangCollege of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.
Yawei SongCenter for Health Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Ke FangCenter for Health Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.ORCID http://orcid.org/0000-0001-7675-6478
Lingling ZhangInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, China.
Gongcheng HuState Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China.ORCID http://orcid.org/0000-0002-6498-0509
Hongjie YaoState Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China. yao_hongjie@gzlab.ac.cn.ORCID http://orcid.org/0000-0003-2144-0147
Guangzhou Institutes of Biomedicine and Health · CNAnhui Medical University · CNFirst Affiliated Hospital of Guangzhou Medical University · CNHenan University · CNShanxi Agricultural University · CNUniversity of Science and Technology of China · CN

Funding

China Postdoctoral Science Foundation (China Postdoctoral Foundation Project) 2022M723167Funding by Science and Technology Projects in Guangzhou, China 202201010117Funding by Science and Technology Projects in Guangzhou, China 202201010157Funding by Science and Technology Projects in Guangzhou, China 202201010755Guangdong Basic and Applied Basic Research Foundation 2022A1515111085Guangdong Basic and Applied Basic Research Foundation 2023A1515010730Guangzhou Key R&D Program 2023B03J1230Major Project of Guangzhou National Laboratory GZNL2023A02008Major Project of Guangzhou National Laboratory GZNL2023A02010MOST | NSFC | National Outstanding Youth Science Fund Project of National Natural Science Foundation of China (IUSS) 31925009National Key R&D Program of China 2021YFA1100300| National Natural Science Foundation of China-Guangdong Joint Fund (-) 32100463| National Natural Science Foundation of China-Guangdong Joint Fund (-) 32300466National Natural Science Foundation of China-Guangdong Joint Fund (-) U21A20195
6 · The paper itself

Abstract

The transition of mouse embryonic stem cells (ESCs) between serum/LIF and 2i(MEK and GSK3 kinase inhibitor)/LIF culture conditions serves as a valuable model for exploring the mechanisms underlying ground and confused pluripotent states. Regulatory networks comprising core and ancillary pluripotency factors drive the gene expression programs defining stable naïve pluripotency. In our study, we systematically screened factors essential for ESC pluripotency, identifying TEAD2 as an ancillary factor maintaining ground-state pluripotency in 2i/LIF ESCs and facilitating the transition from serum/LIF to 2i/LIF ESCs. TEAD2 exhibits increased binding to chromatin in 2i/LIF ESCs, targeting active chromatin regions to regulate the expression of 2i-specific genes. In addition, TEAD2 facilitates the expression of 2i-specific genes by mediating enhancer-promoter interactions during the serum/LIF to 2i/LIF transition. Notably, deletion of Tead2 results in reduction of a specific set of enhancer-promoter interactions without significantly affecting binding of chromatin architecture proteins, CCCTC-binding factor (CTCF), and Yin Yang 1 (YY1). In summary, our findings highlight a novel prominent role of TEAD2 in orchestrating higher-order chromatin structures of 2i-specific genes to sustain ground-state pluripotency.

Indexed as

ChromatinDNA-Binding ProteinsPluripotent Stem CellsTEA Domain Transcription FactorsAnimalsEnhancer Elements, GeneticMiceMouse Embryonic Stem CellsPromoter Regions, GeneticTranscription FactorsChromatinDNA-Binding ProteinsTead2 protein, mouseTEA Domain Transcription FactorsTranscription FactorsAncillary FactorChromatin LoopingEmbryonic Stem CellsGround-state PluripotencyTEAD2

Identifiers

PMID38605224
PMCPMC11099042
OpenAlexW4394718094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.